Most patients received AOM semaglutide (94.1%)
doi:10.3390/IJMS22189936 41
1 In a study published in BMJ , 2 However, in another study, investigators found that GLP-1 treatment was associated with a 98% increased risk of any psychiatric disorder, including 195% for major depression, 108% for anxiety, and 106% for suicidal behavior
The first is endocrine, where GLP-1 enters the bloodstream and reaches the hypothalamus through the area postrema, a region of the brainstem that lacks a complete blood-brain barrier
Research shows that this shot may also have the potential to lower the risk of stroke, diabetes, heart disease and other conditions
doi: 10.1038/s41586-020-2938-9 29 BartokBFiresteinGS